News Related to Hemlibra

Related coverage linked through entity extraction aliases.

Orphan Drug Market Projected to Reach $409 Billion by 2032, Driven by Rare Disease Treatments

Mar 17, 2026

Global orphan drug sales are forecast to reach $409 billion by 2032, representing one-fifth of prescription drug sales, with Johnson & Johnson and Argenx leading the market amid regulatory uncertainty.

CSPC Pharmaceutical Receives China Approvals for Three Clinical Trials

Mar 05, 2026

CSPC Pharmaceutical Group has received approval from China's National Medical Products Administration to begin clinical trials for three drug candidates: a hemophilia A biosimilar, a long-acting pain medication, and an injection designated SYH9089.